Boston Scientific Releases Device that Stimulates the Brain of Parkinson’s Patients

NEC member Boston Scientific has released a new medical device that is meant to treat the symptoms of Parkinson’s disease. The device, known as Vercise, will allow physicians to control the range, shape, position, and direction of electrical stimulation to treat Parkinson’s.

Each year approximately 60,000 Americans are diagnosed with Parkinson’s, with an estimate 1.5 million Americans currently living with the disease. Boston Scientific’s new Vercise device aims to treat these patients by stimulating parts of the brain through implants in the brain. These implants are powered by an implantable pulse generator that sends stimulation to targeted areas of the brain.

“We’re committed to equipping physicians with technology that can improve the lives of patients as their disease progresses,” said Maulik Nanavaty, senior vice president and president, Neuromodulation, Boston Scientific. “Our newest generation Vercise Directional DBS Systems are supported by years of clinical data and real-world experience on the advantages of directionality and offer programming software with features that give physicians the ability to tailor therapy for individual patient needs.”

The New England Council commends Boston Scientific’s work in treating serious illnesses like Parkinson’s, and improving the daily experience and quality of life for these patients.

Read more from the Worcester Business Journal or Boston Scientific’s press release.

Recently from the Blog

NEC Announces COVID In-Person Event Policy; Plans Return to In-Person Programming in 2022

12/17/2021 | Read Post

NEC Launches Technology & Innovation Working Group

01/26/2022 | Read Post

NEC Partnership with internX to Expand Internship Opportunities for Minority Students

01/4/2022 | Read Post

In the News

NEC to Honor Historic All-Female Lineup of 2021 New Englanders of the Year

08/2/2021 | Read Press Release

NEC Board Elects Three New Directors

04/27/2021 | Read Press Release